Clinical study of biapenem

Biapenem (BIPM) was administered to bacterial pneumonia in 9 cases, acute bronchitis in 2 cases, epiglottic abscess in 1 case, pyelonephritis in 1 case and hepatic abscess in 1 case. The drugs were given intravenously for 5-15 days at a dose of 150-600mg, twice per day. Clinical efficacy was excelle...

Full description

Saved in:
Bibliographic Details
Published in:CHEMOTHERAPY Vol. 42; no. Supplement4; pp. 787 - 791
Main Authors: Kono, Kenji, Takeda, Seiji, Tatara, Ichiro, Arakawa, Kikuo, Inoue, Touji, Minamikawa, Hiromichi
Format: Journal Article
Language:English
Japanese
Published: Japanese Society of Chemotherapy 1994
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Biapenem (BIPM) was administered to bacterial pneumonia in 9 cases, acute bronchitis in 2 cases, epiglottic abscess in 1 case, pyelonephritis in 1 case and hepatic abscess in 1 case. The drugs were given intravenously for 5-15 days at a dose of 150-600mg, twice per day. Clinical efficacy was excellent in 5 cases, good in 6 cases, fair in 1 case and excluded in 2 cases. Causative organisms were Haemophilus influenzae (1 case), Escherichia coli (1 case), Streptococcus pneumoniae (1 case), and all them were eradicated. No adverse reaction was observed. The elevated γ-GTP was seen in a patient as to abnormal laboratory finding.
AbstractList Biapenem (BIPM) was administered to bacterial pneumonia in 9 cases, acute bronchitis in 2 cases, epiglottic abscess in 1 case, pyelonephritis in 1 case and hepatic abscess in 1 case. The drugs were given intravenously for 5-15 days at a dose of 150-600mg, twice per day. Clinical efficacy was excellent in 5 cases, good in 6 cases, fair in 1 case and excluded in 2 cases. Causative organisms were Haemophilus influenzae (1 case), Escherichia coli (1 case), Streptococcus pneumoniae (1 case), and all them were eradicated. No adverse reaction was observed. The elevated γ-GTP was seen in a patient as to abnormal laboratory finding.
Author Tatara, Ichiro
Inoue, Touji
Kono, Kenji
Minamikawa, Hiromichi
Takeda, Seiji
Arakawa, Kikuo
Author_xml – sequence: 1
  fullname: Kono, Kenji
  organization: Second Department of Internal Medicine, School of Medicine, Fukuoka University
– sequence: 2
  fullname: Takeda, Seiji
  organization: Second Department of Internal Medicine, School of Medicine, Fukuoka University
– sequence: 3
  fullname: Tatara, Ichiro
  organization: Second Department of Internal Medicine, School of Medicine, Fukuoka University
– sequence: 4
  fullname: Arakawa, Kikuo
  organization: Second Department of Internal Medicine, School of Medicine, Fukuoka University
– sequence: 5
  fullname: Inoue, Touji
  organization: Minamikawa Seikeigeka Hospital
– sequence: 6
  fullname: Minamikawa, Hiromichi
  organization: Minamikawa Seikeigeka Hospital
BookMark eNpdz7tOwzAYBWALFYlQ-gJMeQASfl8S2yOKuEmVGIDZ2Mlv6ipxo8Qd8vYgwVB1OjrDOdJ3TVbxEJGQOwolpayC-3aHwyHtcLLjQnXFS8HK9-M49jhgTMJIJS9IRpUSRaW0WJEMAHTBaV1dkc08BwdAKdRMsYzcNn2IobV9Pqdjt-QHn7tgR4w43JBLb_sZN_-5Jp9Pjx_NS7F9e35tHrbFngmeCkQtO4rSuVZK2yEILWrnBdeOe8pcC7aWFa8saEc1k53WninJLdJaeuB8Tb7-fvdzst9oxikMdlqMnVJoezTnXiOYOfWe1V_-ydROBiP_AQJbYK8
ContentType Journal Article
Copyright Japanese Society of Chemotherapy
Copyright_xml – notice: Japanese Society of Chemotherapy
DOI 10.11250/chemotherapy1953.42.Supplement4_787
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
EISSN 1884-5894
EndPage 791
ExternalDocumentID article_chemotherapy1953_42_Supplement4_42_Supplement4_787_article_char_en
GroupedDBID 53G
AAUGY
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
DIK
JSF
JSH
KQ8
RJT
RZJ
ZOHVM
ID FETCH-LOGICAL-j243t-ee97d1e7bbc77ade04946bf439b3f12bc0a67535a09b1927d99f2873ae167f033
ISSN 0009-3165
IngestDate Thu Aug 17 20:27:58 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue Supplement4
Language English
Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j243t-ee97d1e7bbc77ade04946bf439b3f12bc0a67535a09b1927d99f2873ae167f033
OpenAccessLink https://www.jstage.jst.go.jp/article/chemotherapy1953/42/Supplement4/42_Supplement4_787/_article/-char/en
PageCount 5
ParticipantIDs jstage_primary_article_chemotherapy1953_42_Supplement4_42_Supplement4_787_article_char_en
PublicationCentury 1900
PublicationDate 1994-00-00
PublicationDateYYYYMMDD 1994-01-01
PublicationDate_xml – year: 1994
  text: 1994-00-00
PublicationDecade 1990
PublicationTitle CHEMOTHERAPY
PublicationTitleAlternate Chemother.
PublicationYear 1994
Publisher Japanese Society of Chemotherapy
Publisher_xml – name: Japanese Society of Chemotherapy
References 2) Hikida M, kawashima K, Yoshida M and Mitsuhashi S: Inactivation of new carbapenem antibiotics by dehydropeptidase-I from procine and human renal cortex. J. Antimicrob Chemother 30: 129-134, 1992
1) Ubukata K, Hikida M, Yoshida M, Nishiki K, Furukawa Y, Tashiro K, Konno M and Mitsuhashi S: In vitro activity of LJC 10, 627, a new carbapenem antibiotic with high stability to dehydropeptidase-I. Antimicrob Agents Chemother. 34: 994-1000, 1990
3) Hikida M, Kawashima K, Nishiki K, Furukawa Y, Nishizawa K, Saito I and Kuwao S: Renal dehydropeptidase-I stability of LJC 10627, a new carbapenem antibiotic. Antimicrob Agents Chemother. 36: 481-483, 1992
References_xml
SSID ssib001106282
ssj0000626693
ssib031782880
ssib005879733
ssib008506721
Score 1.2436526
Snippet Biapenem (BIPM) was administered to bacterial pneumonia in 9 cases, acute bronchitis in 2 cases, epiglottic abscess in 1 case, pyelonephritis in 1 case and...
SourceID jstage
SourceType Publisher
StartPage 787
SubjectTerms Biapenem
Title Clinical study of biapenem
URI https://www.jstage.jst.go.jp/article/chemotherapy1953/42/Supplement4/42_Supplement4_787/_article/-char/en
Volume 42
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX CHEMOTHERAPY, 1994/12/28, Vol.42(Supplement4), pp.787-791
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fSyMxEA5VQXw57lBRz5N9uDfdurtJm-RRtKIIKlpBn5bJbha3RSu1RfzvnST7I3ovCufL0gYyNDvDl2_SzHyE_GUCEgFShVwqGiK_1aEEcwUKd48cJFdQWBHba35-K44GbNDp1CpZ7di3ehrH0NemcvYL3m6M4gB-Rp_jE72Oz0_5_bApdazbRasSnhDRHnweajohXAxPBlcHlw2XPXMy3KZUZ1S2Gf1Y55ZgXuvSH56BVSjaPc3uy-mkjRsYw4srMyvH80l7qGC6A7dQj1u0kb5sLo3aSyH6oSoHe32HpRIR3Ck9dLWDTyFY2BOVvQpfWeLFkdUqtQefzINNXm26bgfmTr_rX3BHuoavP_N-jvkTsMuSrmc2bYy9a6NdOST9ODtlSerP_vAVjaXtVJhiiC2QpQRRzchlHJ2etdwzNuWoXu8zwSX3uLRpDej1okPehsluBZ6ONiBXko3yn3mzy2SvXvf-J1aNJGqEKUV9HdEypOFP8qNKbYIDt45fpDOCVbJVx2Ng4zGYFEEdj2vk5ngwPDwJKz2OcJQwOgu1ljyPNVcq4xxybVoL9VWBlFbRIk5UFgGmn7QHkVSYOPBcygITcgo67vMionSdLD5OHvUGCfrILDktsp4QwLIY0QKYqYqOKM9xXrRJ7txS0ifXdCX9f_7b-kbbv8mKa7Ztzui2yeJsOtd_yMJzPt-x0fIGUzWd-Q
link.rule.ids 315,782,786,4028,27932,27933,27934
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+study+of+biapenem&rft.jtitle=CHEMOTHERAPY&rft.au=Kono%2C+Kenji&rft.au=Takeda%2C+Seiji&rft.au=Tatara%2C+Ichiro&rft.au=Arakawa%2C+Kikuo&rft.date=1994&rft.pub=Japanese+Society+of+Chemotherapy&rft.issn=0009-3165&rft.eissn=1884-5894&rft.volume=42&rft.issue=Supplement4&rft.spage=787&rft.epage=791&rft_id=info:doi/10.11250%2Fchemotherapy1953.42.Supplement4_787&rft.externalDocID=article_chemotherapy1953_42_Supplement4_42_Supplement4_787_article_char_en
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-3165&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-3165&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-3165&client=summon